Search Results - "Gilks, C.Blake"

  • Showing 1 - 11 results of 11
Refine Results
  1. 1

    Mucinous borderline ovarian tumors: Points of general agreement and persistent controversies regarding nomenclature, diagnostic criteria, and behavior by Ronnett, Brigitte M, Kajdacsy-Balla, AndrÉ, Gilks, C.Blake, Merino, Maria J, Silva, Elvio, Werness, Bruce A, Young, Robert H

    Published in Human pathology (01-08-2004)
    “…This report focuses on the borderline category of ovarian mucinous tumors and summarizes the points of general agreement and persistent controversies…”
    Get full text
    Journal Article Conference Proceeding
  2. 2

    Tissue microarray analysis of neuroendocrine differentiation and its prognostic significance in breast cancer by Makretsov, Nikita, Gilks, C.Blake, Coldman, Andrew J, Hayes, Malcolm, Huntsman, David

    Published in Human pathology (01-10-2003)
    “…The aim of this study was to detect neuroendocrine differentiation (NE), to determine its association with major clinicopathological parameters of breast…”
    Get full text
    Journal Article
  3. 3

    Low grade serous carcinoma of the peritoneum in a BRCA1 carrier previously diagnosed with a “low-grade serous tubal intra-epithelial carcinoma” (STIC) on risk reducing surgery by Chay, Wen Yee, Horlings, Hugo M, Tinker, Anna V, Gelmon, Karen A, Gilks, C.Blake

    Published in Gynecologic oncology reports (01-04-2015)
    “…Highlights • Conventional definitions of STIC do not capture all lesions associated with serous neoplasia and the presence of abnormal p53 expression may be…”
    Get full text
    Journal Article
  4. 4
  5. 5

    Giant cell tumor of tendon sheath is a polyclonal cellular proliferation by Vogrincic, Gerard S, O'connell, John X, Gilks, C.Blake

    Published in Human pathology (01-07-1997)
    “…Giant cell tumor of tendon sheath (GCTTS) is a common soft tissue tumor. Immunophenotypical evidence suggests it is of synovial cell origin. There is…”
    Get full text
    Journal Article
  6. 6

    Low-Risk Endometrial Carcinoma: Assessment of a Treatment Policy Based on Tumor Ploidy and Identification of Additional Prognostic Indicators by Lim, Peter, Aquino-Parsons, Christina F., Wong, Frances, Dupuis, Bev, Phillips, Don, Zhou, Chen, Gilks, C.Blake

    Published in Gynecologic oncology (01-05-1999)
    “…Objectives.The aims of this study were (1) to assess a treatment policy for patients with low-risk endometrioid endometrial carcinoma where adjuvant treatment…”
    Get full text
    Journal Article
  7. 7
  8. 8

    Loss of desmoglein 1 expression associated with worse prognosis in head and neck squamous cell carcinoma patients by Wong, Michelle P., Cheang, Maggie, Yorida, Erika, Coldman, Andrew, Gilks, C.Blake, Huntsman, David, Berean, Ken

    Published in Pathology (01-10-2008)
    “…Mucosal squamous cell carcinomas are the most common head and neck malignancies. We hypothesised that over-expression of intracellular signalling proteins and…”
    Get full text
    Journal Article
  9. 9

    Oviductal glycoprotein, a new differentiation-based indicator present in early ovarian epithelial neoplasia and cortical inclusion cysts by Woo, Michelle M.M, Gilks, C.Blake, Verhage, Harold G, Longacre, Teri A, Leung, Peter C.K, Auersperg, Nelly

    Published in Gynecologic oncology (01-05-2004)
    “…Objective. With neoplastic progression, the precursor of epithelial ovarian cancers, the ovarian surface epithelium (OSE), undergoes Mullerian differentiation,…”
    Get full text
    Journal Article
  10. 10
  11. 11

    Recurrent endometrial adenocarcinoma: presentation as a splenic mass mimicking malignant lymphoma by Gilks, C B, Acker, B D, Clement, P B

    Published in Gynecologic oncology (01-05-1989)
    “…We report the case of a 72-year-old woman in whom the sole manifestation of recurrent endometrial adenocarcinoma was a large splenic mass. The clinical…”
    Get more information
    Journal Article